ClinicalTrials.gg
RecruitingNCT01974362Updated Oct 15, 2026

Monolithic Zirconia Full-Mouth Implant Supported Rehabilitation Behavior

An observational study in Endosseous Dental Implant Failure and Accident Caused by Broken Ceramic, sponsored by Implantology Institute. Recruiting at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Implantology Institute · Observational

From the registry’s dates

  • Started Jan 2014; still recruiting 12 years 10 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
90
Ages
18 Years and older
Sex
All
01

Study summary

In patients rehabilitated with a full-arch (maxillary and/or mandibular) implant-supported fixed prosthesis, do three CAD/CAM zirconia framework designs - porcelain-veneered zirconia (PVZ), monolithic zirconia with buccal veneer (MZ) and full-contour monolithic zirconia (FCMZ) - differ in the incidence of post-insertion technical complications, in particular ceramic chipping, and in prosthesis survival and success after at least 1 year in function?

This prospective observational study, conducted in a private clinical setting, compares the three designs regarding technical and biological complications, prosthesis survival and success (Alpha/Bravo/Charlie/Delta classification) and implant success, and examines the influence of arch, number of implants, opposing dentition and cantilever extension on the occurrence of complications.

Read the detailed description

Study the behavior of implant supported rehabilitations made from full-zirconium dioxide (monolithic with buccal veneer (MZ) or full contour monolithic (FCMZ) ) and zirconia veneered with feldspathic (PVZ) in full-mouth type of rehabilitations (maxilla and mandible).

In a private clinic we will record the behavior, regarding prosthodontic and biological complications in different groups (MZ vs FCMZ vs PVZ) after at least 1 year in function.

We will make calibration of the investigators for prosthodontic and biological assessement and accepting an inter-observer agreement (Kappa) of 0.9 for each parameter.

Recording will be made without the help of magnifying utilities such as magnifying glasses or optical microscopes.

02

Conditions studied

  • Endosseous Dental Implant Failure
  • Accident Caused by Broken Ceramic

Browse trials for

Keywords

  • Monolithic Zirconia
  • Zirconia-Feldspathic zirconia
  • Dental Implants
  • Fracture
  • Chipping
03

In context

Fractures, Bone

723 studies on the registry are indexed under Fractures, Bone; 114 are open to participants now.

This study's planned enrollment of 90 is below the median of 130 across 239 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Implantology Institute is the lead sponsor of 17 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients from a dental office that did a full-mouth (bimaxillary - maxilla and/or mandible) implant-supported rehabilitation and made the final rehabilitation with either monolithic zirconia or in feldspathic-zirconia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Maxilla and/or Mandible Implant full-mouth restoration
  • Monolithic ceramic or zirconia-feldspathic restoration
  • be at least 18 years of age;
  • present no systemic or local absolute for endosseous implant placement;
  • at least 1 Year Follow-up

Exclusion criteria

Exclusion Criteria:

  • the presence of any systemic disease or condition that could compromise postoperative healing or osseointegration.
  • Not full mouth rehabilitation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
90 participants (estimated)
Patient registry
No

Groups and cohorts

  • Monolithic Zirconia with Buccal Veneer (MZ)

    Patients that have a full-mouth (maxilla and/or mandible) dental implant supported rehabilitation restored with monolithic zirconia biomaterial with buccal veneers

    Device: Dental Implant · Device: Monolithic Zirconia (MZ)

  • Monolithic Zirconia full-contour (FCMZ)

    Patients that have a full-mouth (maxilla and/or mandible) dental implant supported rehabilitation restored with monolithic zirconia biomaterial full contour (without veneer)

    Device: Dental Implant · Device: Monolithic Zirconia (FCMZ)

  • Zirconia-Feldspathic (PVZ)

    Patients that have a full-mouth (maxilla and/or mandible) implant supported rehabilitation restored with zirconia substructure and feldspathic veneered biomaterial

    Device: Dental Implant · Device: Zirconia-Feldspathic (PVZ)

Interventions

  • DeviceDental Implant

    Place dental implants in both jaws (maxilla and mandible) according to manufacturer specifications

    Also known as: Dental Fixtures

  • DeviceMonolithic Zirconia (MZ)

    rehabilitation with monolithic zirconia implant-prosthesis with bucal feldspathic veneer

    Also known as: Prettau®, Zirkonzhan®

  • DeviceZirconia-Feldspathic (PVZ)

    restore dental implants with a zirconia suprastructure and feldspathic veneers

    Also known as: Ice Ceramic ® Zirkonzhan®

  • DeviceMonolithic Zirconia (FCMZ)

    Full contour full arch zirconia rehabilitation

    Also known as: Prettau®, Zirkonzhan®

06

What researchers measure

Primary outcomes

  1. Total Amount of Chipping

    measure the total number of ceramic fractures (chipping) visible at naked eye in both groups (monolithic and feldspathic) that happen from insertion (baseline) to last follow-up visit Primary outcomes are defined as survival and success rates of the final prosthesis. For evaluation of these outcomes, an analysis variable will be used (Mendez Caramês et al., 2016): if no alterations are present, the prosthesis will be recorded as "Alpha"

    Time frame: at least 1-Year post-insertion

  2. Number of Small Complications

    Measure the total amount of adverse events other than chipping, that made the patient come to the dental office, that happen from insertion (baseline) to last follow up visit It is determined that if the complication was solved in the dental chair is considered a Small complication/minor chipping - not requiring any intervention besides polishing or recontouring without the need for prosthesis retrieval-"Bravo" classification will be attributed

    Time frame: at least 1-year post-insertion

  3. Number of Big Complications

    Measure the total amount of adverse events other than chipping, that made the patient come to the dental office, that happen from insertion (baseline) to last follow up. It is determined that if the complication was solved in the dental laboratory is considered a big complication/major chipping - a "Charlie" classification will indicate the occurrence of major chipping, need for prosthesis retrieval and laboratory intervention;

    Time frame: at least 1-Year post Insertion

  4. Number of prosthesis failures

    a "Delta" classification will be attributed when fracture of the framework is present, defining a non-surviving prosthesis

    Time frame: at least 1-year post insertion

Secondary outcomes

  1. Biological complications

    implant success rates will be evaluated; absence of persistent subjective complaints (pain, foreign body sensation, and/ or dysesthesia); absence of peri-implant infection with suppuration; absence of implant mobility; and absence of continuous radiolucency around the implant by previously established methods based on the clinical and radiographic examinations at the yearly visits

    Time frame: at least 1-Year post insertion

07

Study locations

1 of 1 sites recruiting
  • Artur Simões
    Lisbon, Lisbon District 1070-061, Portugal
    Recruiting
    • Artur Simões · Contactartursimoes@institutoimplantologia.com
    • João Caramês, Phd · Principal investigator
    • Pedro Crispim, Msc · Sub investigator
    • Helena Francisco, Phd · Sub investigator
    • Andre Moreira, Phd · Sub investigator
    • Duarte Marques, Phd · Sub investigator
    • Artur Simões, Msc · Principal investigator
08

References and documents

Publications

  • Carames J, Marques D, Malta Barbosa J, Moreira A, Crispim P, Chen A. Full-arch implant-supported rehabilitations: A prospective study comparing porcelain-veneered zirconia frameworks to monolithic zirconia. Clin Oral Implants Res. 2019 Jan;30(1):68-78. doi: 10.1111/clr.13393. Epub 2018 Dec 30. PubMed 30521106 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2014 (actual). Primary completion is estimated for Jan 2028, 168 months after the start.

Of 66 non-industry observational studies under Fractures, Bone, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 88. This study's planned 168 months is above that.

Counting every sponsor, half of 86 studies reached it within 46 months; a quarter within 20 and three quarters within 124.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2013
First posted
Nov 1, 2013
StartActual
Jan 2014
Primary completionEst.
Jan 1, 2028
CompletionEst.
Dec 31, 2029
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and description
1 update, last Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Minor edits only
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT01974362
Lead sponsor
Implantology Institute
Responsible party
Sponsor
First posted
Nov 1, 2013
Start date
Jan 2014
Primary completion
Jan 1, 2028 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Oct 15, 2026

Study contacts

João Caramês, Phd
study director · Implantology Institute
Artur Simões, Msc
principal investigator · Implantology Institute
Duarte Marques, Msc
study director · Implantology Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion